Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.36 USD | +2.14% | -7.44% | +243.47% |
May. 17 | Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform | MT |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+243.47% | 6.95B | |
+11.10% | 115B | |
+12.70% | 106B | |
-4.33% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.64% | 17.56B | |
-39.36% | 17.32B | |
+7.38% | 14.03B | |
+32.86% | 12.13B |
- Stock Market
- Equities
- VKTX Stock
- News Viking Therapeutics, Inc.
- Oppenheimer Adjusts Viking Therapeutics Price Target to $15 From $13, Maintains Outperform Rating